Form 4 for EW Edwards Lifesciences
Accepted 2022-04-11 00:00:00 ET · period of report 2022-04-08 · accession 0001225208-22-005750 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-11 | 2022-04-08 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +11.7K | 164.0K | +8% | +$253.7K |
| DM | 2022-04-11 | 2022-04-08 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $123.29 | -11.7K | 163.9K | -7% | -$1.44M |
| D | 2022-04-11 | 2022-04-08 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $0.00 | -11.7K | 11.6K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-08 | M | A | 11,660 | $21.76 | 163,986.34 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-08 | S | D | 11,560 | $123.29 | 152,326.34 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $122.57 to $123.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-04-08 | S | D | 100 | $123.57 | 163,886.34 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Acquire) | 2022-04-08 | M | D | 11,660 | $0.00 | 11,560 | D | $21.76 · 2016-05-14 to 2022-05-13 | 11,660 Common Stock |